Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neuritis 1 Neoplasms 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Esthesioneuroblastoma, Olfactory 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 66 Radiotherapy 34 Carboplatin 22 Carmustine 21 Bevacizumab 21 Irinotecan 18 Filgrastim 18 Surgical Procedures, Operative 14 Vincristine 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 11 Radiation 10 O(6)-benzylguanine 10 Magnetic Resonance Spectroscopy 9 Lomustine 9 Procarbazine 8 Erlotinib Hydrochloride 8 sargramostim 7 IL13-PE38 7 Everolimus 7 Cyclophosphamide 7 Chemotherapy, Adjuvant 7 Thiotepa 6 Radiotherapy, Intensity-Modulated 6 Imatinib Mesylate 6 Granulocyte Colony-Stimulating Factor 6 Drug Therapy 6 Cisplatin 6 temsirolimus 5 antineoplaston AS 2-1 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Astrocytoma × Diffusion Tensor Imaging × Clear all

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡